Skip to main content

Table 1 PCR primers, cycling conditions and positive controls used.

From: Characterization of EN-1078D, a poorly differentiated human endometrial carcinoma cell line: a novel tool to study endometrial invasion in vitro

Primer

Sens Primer

Antisense Primer

Size (bp)*

annealing (celsius)

cycles

extension

positive control

Keratin 1

5'-gatgaaggccacggtgatca-3'

5'-gacttgagttggggtgccta-3'

627

64

36

1 min

KLE

Keratin 4

5'-ctccagcaaaaaccttgagc-3'

5'-aagtcattctcggctgctgt-3'

186

58

36

30 sec

KLE

Keratin 5

5'-tctcgccagtcaagtgtgtc-3'

5'-atagccacccactccacaag-3'

247

58

36

30 sec

KLE

Keratin 7

5'-caggatgtggtggaggactt-3'

5'-ttgctcatgtaggcagcatc-3'

116

58

30

30 sec

KLE

Keratin 8

5'-agatgaaccggaacatcagc-3'

5'-tccagcagcttcctgtaggt-3'

262

58

30

30 sec

KLE

Keratin 13

5'-gtcttcagcacccagaggag-3'

5'-ttgcagaaaggcaggaaact-3'

246

58

36

30 sec

Hec-1-A

Keratin 18

5'-cacagtctgctgaggttgga-3'

5'-gagctgctccatctgtaggg-3'

164

58

36

30 sec

KLE

Keratin 19

5'-tttgagacggaacaggctct-3'

5'-gccatgacctcatattggct-3'

275

58

30

30 sec

KLE

Keratin 20

5'-acgccagaacaacgaatacc-3'

5'-acgaccttgccatccactac-3'

198

61

36

30 sec

KLE

Vimentin

5'-gagaactttgccgttgaagc-3'

5'-tccagcagcttcctgtaggt-3'

170

58

36

30 sec

KLE

Desmin

5'-caagctgcaggaggagattc-3'

5'-ggcagtgaggtctggcttag-3'

241

62

36

30 sec

KLE

ER alpha

5'-gtgcctggctagagatcctg-3'

5'-agagacttcagggtgctgga-3'

265

66

36

30 sec

MCF-7

ER beta

5'-tcaggcatgcgagtaacaag-3'

5'-gcttttactgtcctctgccg-3'

167

65

36

30 sec

MCF-7

PR-A

5'-gcttcaagttagccaagaagagt-3'

5'-ctggaaattcaacactcagtg-3'

290

58

36

30 sec

Ishikawa

PR-B

5'-acaccttgcctgaagtttcg-3'

5'-tccaagacactgtccagcag-3'

160

64

35

30 sec

Ishikawa

MMP-2

5'-aggcaagtggtccgtgtgaa-3'

5'-acagtggacatggcggtctcag-3'

369

66

36

30 sec

KLE

MMP-9

5'-caacatcacctattggatcc-3'

5'-cgggtgtagagtctctcgct-3'

479

60

36

30 sec

KLE

MMP-14

5'-ccagggtctcaaatggcaaca-3'

5'-ccatggaagccctcggcaaa-3'

219

66

36

30 sec

**

TIMP-1

5'-accagaccaccttataccagcg-3'

5'-ggactggaagcccttttcagag-3'

395

58

36

30 sec

RL-95-2

TIMP-2

5'-atgcagatgtagtgatcagggc-3'

5'-gatgaagtcacagagggtgatg-3'

272

58

36

30 sec

RL-95-2

β-actin

5'-gaggatcttcatgaggtagtctgtcaggtc-3'

5'-caactgggacgacatggagaagatctggca-3'

348

58

25

30 sec

none

  1. * Size of amplified fragment; ** PMA-treated THP-1 cells